Study Investigating Rapamune For Post-Marketing Surveillance

CompletedOBSERVATIONAL
Enrollment

209

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Kidney Transplantation
Interventions
DRUG

sirolimus

Dosage and treatment duration will be decided by physician's discretion considering patient's clinical situations

Trial Locations (11)

110-744

Seoul National University Hospital (SNUH), Seoul

705-717

Yeungnam University Medical Center, Daegu

480-717

The Catholic University of Korea Uijeongbu St. Mary's Hospital, Gyeonggi-do

600-730

Maryknoll Medical Center, Pusan

134-814

Kangdong Sacred Heart Hospital, Seoul

135-710

Samsung Medical Center, Seoul

135-720

Gangnam Severance Hospital, Yonsei University Health System, Seoul

136-705

Korea University Anam Hospital, Seoul

137-701

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

138-736

Asan Medical Center, Seoul

143-729

Konkuk University Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00484094 - Study Investigating Rapamune For Post-Marketing Surveillance | Biotech Hunter | Biotech Hunter